Ziena Abdulrahman

7PUBLICATIONS
11CO-AUTHORS
Innate immunityTumour immunologyCellular immunologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 21, 2025
Pre-existing infiltration with T cells and CD14+ myeloid cells is associated with treatment response to imiquimod in primary and recurrent vulvar high-grade squamous intraepithelial lesions.

Caroline L P Muntinga, Peggy J de Vos van Steenwijk, Loes F S Kooreman

|Mar 13, 2025
Single-cell spatial transcriptomics unravels cell states and ecosystems associated with clinical response to immunotherapy.

Ziena Abdulrahman, Roderick C Slieker, Daniel McGuire

|Nov 02, 2022
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions.

Ziena Abdulrahman, Natasja Hendriks, Arnold J Kruse

|Feb 26, 2022
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival.

Ziena Abdulrahman, Saskia J Santegoets, Gregor Sturm

|Jan 18, 2022
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.

Chantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman

|Sep 03, 2020
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.

Elham Beyranvand Nejad, Camilla Labrie, Ziena Abdulrahman

Pageof 2

Frequent Collaborators

5 joint publications

Sjoerd H van der Burg

3 joint publications

Noel F C C de Miranda

2 joint publications

Ramon Arens

2 joint publications

Saskia J Santegoets